NCT00747227|CompletedPhase 3Results
Safety and Efficacy of a Violet Visible Light Blocking Intraocular Lens (IOL)
Clinical Evaluation of a Modified Light Transmission IOL
Loading search results
Sponsor study identifier
interventional
250
1 country
11
Study Start
December 2006
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
March 2009
Actual (reported)Study Completion
June 2009
Actual (reported)The purpose of this study is to evaluate the safety and effectiveness of a new investigational modified light transmission monofocal intraocular lens compared to a conventional intraocular lens (IOL).
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 2009
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
December 2006
Date type not reportedThis date has not been verified as actual or estimated.
September 3, 2008
Actual (reported)September 5, 2008
Actual (reported)March 2009
Actual (reported)June 2009
Actual (reported)November 11, 2011
Actual (reported)Best Corrected Distance Visual Acuity
Snellen Equivalent visual acuity of 20/40 or better
One year
Uncorrected Distance Visual Acuity
Snellen Equivalent of 20/40 or better at one year
One Year
Contrast Sensitivity
4-6 months
Subject Satisfaction - Subjects Satisfied With Overall Eyesight Rated as "Good" or "Excellent".
One Year
modified light transmission intraocular lens
monofocal acrylic intraocular lens
violet visible light blocking acrylic intraocular lens
conventional hydrophobic acrylic intraocular lens
Patrick Aiello, M.D.
Scottsdale, Arizona, 85054, United States
Randall E. Cole, M.D.
Rogers, Arkansas, 72756, United States
Aron Rose, M.D.
New Haven, Connecticut, 06510, United States
Y. Ralph Chu, M.D.
Bloomington, Minnesota, 55420, United States
Steven Silverstein, M.D.
Kansas City, Missouri, 64133, United States
Jon-Marc Weston, M.D.
Roseburg, Oregon, 97470, United States
William Christie, M.D.
Cranberry Township, Pennsylvania, 16066, United States
Roger F. Steinert, M.D.
University of California, Irvine, Dept. of Ophthalmology
250 participants (actual enrollment reported by the registry).
First Submitted
September 3, 2008
First Posted
September 5, 2008
Study Start
December 2006
Date type not reportedThis date has not been verified as actual or estimated.
Safety and Efficacy of Next Generation Ophthalmic Irrigating Solution Compared to BSS Plus
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Mark Blecher, M.D.
Philadelphia, Pennsylvania, 19148, United States
Robert L. Bahr, M.D.
Providence, Rhode Island, 02906, United States
Vance Thompson, M.D.
Sioux Falls, South Dakota, 57105, United States
Jay Rudd, M.D.
Lacey, Washington, 98503, United States
Primary Completion
March 2009
Actual (reported)Study Completion
June 2009
Actual (reported)Last Updated
November 11, 2011
Results First Posted
November 11, 2011
Record last verified: 2011-10
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: